152 related articles for article (PubMed ID: 18300358)
1. Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.
Zhang M; Li B; Yan LN; Yin F; Wen TF; Zeng Y; Zhao JC; Ma YK
World J Gastroenterol; 2008 Feb; 14(8):1280-5. PubMed ID: 18300358
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.
Campsen J; Zimmerman M; Trotter J; Hong J; Freise C; Brown R; Cameron A; Ghobrial M; Kam I; Busuttil R; Saab S; Holt C; Emond J; Stiles J; Lukose T; Chang M; Klintmalm G
Liver Transpl; 2013 Sep; 19(9):1020-9. PubMed ID: 23852663
[TBL] [Abstract][Full Text] [Related]
3. Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.
Hu Z; Zhou J; Wang H; Zhang M; Li S; Huang Y; Wu J; Li Z; Zhou L; Zheng S
PLoS One; 2013; 8(4):e61620. PubMed ID: 23613886
[TBL] [Abstract][Full Text] [Related]
4. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.
Lin YJ; Lee MH; Yang HI; Jen CL; You SL; Wang LY; Lu SN; Liu J; Chen CJ
PLoS One; 2013; 8(4):e61448. PubMed ID: 23613855
[TBL] [Abstract][Full Text] [Related]
5. Clinical conditions and treatment requirements for long-term survival among hepatitis B-related hepatocellular carcinoma initially treated with chemoembolization.
Chen ZX; Jian ZW; Wu XW; Wang JC; Peng JY; Lao XM
Cancer Med; 2019 Sep; 8(11):5097-5107. PubMed ID: 31313476
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.
Yaghi C; Sharara AI; Rassam P; Moucari R; Honein K; BouJaoude J; Slim R; Noun R; Abdul-Baki H; Khalifeh M; Ramia S; Sayegh R
World J Gastroenterol; 2006 Jun; 12(22):3575-80. PubMed ID: 16773714
[TBL] [Abstract][Full Text] [Related]
8. The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.
Lu D; Yang F; Zhuo J; Yang M; Lin Z; Jin P; Cai X; Cen B; Wang J; Wei X; Zheng S; Xu X
Clin Transl Gastroenterol; 2020 May; 11(5):e00168. PubMed ID: 32358239
[TBL] [Abstract][Full Text] [Related]
9. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
11. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Ventura Y; Carr BI; Kori I; Guerra V; Shibolet O
World J Gastroenterol; 2018 Apr; 24(15):1641-1649. PubMed ID: 29686471
[TBL] [Abstract][Full Text] [Related]
12. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.
Halazun KJ; Rosenblatt RE; Mehta N; Lai Q; Hajifathalian K; Gorgen A; Brar G; Sasaki K; Doyle MBM; Tabrizian P; Agopian VG; Najjar M; Ivanics T; Samstein B; Brown RS; Emond JC; Yao F; Lerut J; Rossi M; Mennini G; Iesari S; Finkenstedt A; Schaefer B; Mittler J; Hoppe-Lotichius M; Quintini C; Aucejo F; Chapman W; Sapisochin G
JAMA Surg; 2021 Jun; 156(6):559-567. PubMed ID: 33950167
[TBL] [Abstract][Full Text] [Related]
13. The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance.
Sellers CM; Uhlig J; Ludwig JM; Taddei T; Stein SM; Lim JK; Kim HS
Cancer Med; 2019 Oct; 8(13):5948-5958. PubMed ID: 31436905
[TBL] [Abstract][Full Text] [Related]
14. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
15. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
16. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria.
De Giorgio M; Vezzoli S; Cohen E; Armellini E; Lucà MG; Verga G; Pinelli D; Nani R; Valsecchi MG; Antolini L; Colledan M; Fagiuoli S; Strazzabosco M
Liver Transpl; 2010 Apr; 16(4):503-12. PubMed ID: 20373461
[TBL] [Abstract][Full Text] [Related]
17. A score model for predicting post-liver transplantation survival in HBV cirrhosis-related hepatocellular carcinoma recipients: a single center 5-year experience.
Wang LY; Zheng SS; Xu X; Wang WL; Wu J; Zhang M; Shen Y; Yan S; Xie HY; Chen XH; Jiang TA; Chen F
Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):43-9. PubMed ID: 25655289
[TBL] [Abstract][Full Text] [Related]
18. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Xiao GQ; Yang JY; Yan LN
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
[TBL] [Abstract][Full Text] [Related]
19. [A new model for survival assessment based on the Chinese liver transplantation patients with hepatocellular carcinoma].
Zhang M; Li B; Yin F; Yan LN; Zeng Y; Wen TF; Zhao JC; Luo YL
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(15):1023-6. PubMed ID: 18005580
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
Wu TJ; Chan KM; Chou HS; Lee CF; Wu TH; Chen TC; Yeh CT; Lee WC
Ann Surg Oncol; 2013 Oct; 20(11):3582-90. PubMed ID: 23760589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
